4.6 Article

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer

期刊

CANCERS
卷 11, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/cancers11070914

关键词

bladder cancer; recurrence prediction; biomarker; metabolite; metabolomics; metabolic pathways; nuclear magnetic resonance

类别

资金

  1. FEDER [MAT2015-64139-C4-1-R, MAT2015-64139-C4-2-R, RTI2018-100910-B-C41, RTI2018-100910-B-C43, ISCIII-RETICRD12/0036/0009, CTQ2016-79561-P, PROMETEO II/2014/047, PROMETEO 2018/024]

向作者/读者索取更多资源

Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this tumor. Nevertheless, these techniques have some drawbacks, namely, low accuracy in detection of low-grade tumors, omission of pre-neoplastic lesions and carcinomas in situ (CIS), invasiveness, and high costs. This work aims to identify a urinary metabolomic signature of recurrence by proton Nuclear Magnetic Resonance (H-1 NMR) spectroscopy for the follow-up of NMIBC patients. To do this, changes in the urinary metabolome before and after transurethral resection (TUR) of tumors are analyzed and a Partial Least Square Discriminant Analysis (PLS-DA) model is developed. The usefulness of this discriminant model for the detection of tumor recurrences is assessed using a cohort of patients undergoing monitoring. The trajectories of the metabolomic profile in the follow-up period provide a negative predictive value of 92.7% in the sample classification. Pathway analyses show taurine, alanine, aspartate, glutamate, and phenylalanine perturbed metabolism associated with NMIBC. These results highlight the potential of H-1 NMR metabolomics to detect bladder cancer (BC) recurrences through a non-invasive approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据